Decentralized clinical trials_hero

Although it was the COVID-19 pandemic that pushed decentralized clinical trials (DCTs) to the forefront, they had been around for nearly a decade. And while DCTs may increase access to and diversity in clinical trials, study sponsors must ensure participants are safe and protected, while maintaining data integrity.

When you hear DCT, you automatically think it’s going to be more convenient.
Teonna Woolford, CEO of SCRed

Related resources

A diverse group of people sitting in a waiting room together.
JUL 12, 2023
Patient Engagement & Recruitment

The Need for Clinical Trial Diversity: How We Got Here and Where We're Headed

Clinical trial diversity, the inclusion of underrepresented segments of the population in medical research, is a crucial component of health equity.

Thumbnail of the Supporting Diversity in Clinical Trial Recruitment Infographic PDF.
Patient Engagement & Recruitment

Supporting Diversity in Clinical Trial Recruitment

See how the Citeline Connect Recruitment Collective partnership network drives study awareness and participation globally.

holographic image of people walking
SEP 06, 2023

Technology & the Triple Aim of Trial Recruiting

The search for a clinical trial match has led patients and caregivers online. All stakeholders must be connected and vetted via available technology.